Cannabinoid modulation of limbic forebrain noradrenergic circuitry
Both the endocannabinoid and noradrenergic systems have been implicated in neuropsychiatric disorders. Importantly, low levels of norepinephrine are seen in patients with depression, and antagonism of the cannabinoid receptor type 1 (CB1R) is able to induce depressive symptoms in rodents and humans....
Autor principal: | |
---|---|
Outros Autores: | , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2010
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/1822/67527 |
País: | Portugal |
Oai: | oai:repositorium.sdum.uminho.pt:1822/67527 |